成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Antineoplastic agents>Hormonal antineoplastic drugs>Raloxifene
Raloxifene
  • Raloxifene
  • Raloxifene

Raloxifene

Price Get Latest Price
Package 1Kg/Bag
Min. Order: 100g/Bag
Supply Ability: 1000KG
Update Time: 2021-11-09

Product Details

Product Name: Raloxifene CAS No.: 84449-90-1
Min. Order: 100g/Bag Purity: 99.4%
Supply Ability: 1000KG Release date: 2021/11/09

Quick detail


Name: Raloxifene
CAS No.: 84449-90-1
Formula: C28H27NO4S
Molecular Weight: 473.58
Synonyms: Keoxifene;LY 139481;[2-(4-Hydroxyphenyl)-6-hydroxybenzo[b]thien-3-yl][4-(2-(1-piperidinyl)ethoxy)phenyl]methanone;
Density: 1.289 g/cm3
Melting Point: 250-253 °C
Boiling Point: 728.2 °C at 760 mmHg
Flash Point: 394.2 °C
Solubility: DMSO: 28 mg/mL, soluble
Appearance: light-yellow solid

Product Categories: Raloxifene;Intermediates & Fine Chemicals;Pharmaceuticals;Pharmaceutical intermediate

Usage : A nonsteroidal estrogen receptor mixed agonist/antagonist

 

Raloxifene Description


Raloxifene, a member of the class of selective estrogen receptor modulators (SERM), reproduces the beneficial effects of estrogens on the skeletal systems, without the negative effects estrogens on breast and endometrium.

This is a review article summarizing its mechanism, effects on bone and its applicability in traumatology clinical practice. In postmenopausal osteoporosis, this drug has been proven to decrease accelerated bone turnover, increase bone mineral density (BMD), and to structurally recover bone, decreasing the risk of vertebral fractures and the risk of non-vertebral fractures in patients with previous, severe vertebral fractures.

 

Moreover, raloxifene appears to lower the risk of invasive breast cancer. Raloxifene would be efficacious in the prevention and treatment of postmenopausal osteoporosis.

We can therefore conclude that raloxifene would be efficacious in the prevention and treatment of postmenopausal osteoporosis, while reducing the risk of breast cancer when used at the indicated dose of 60 mg/day and with a low incidence of side effects.

  • Keywords: Raloxifene, SERM, postmenopausal osteoporosis, osteoporotic fracture.

 

Before taking raloxifene,

  1. tell your doctor and pharmacist if you are allergic to raloxifene or any other medications.

  2. tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: anticoagulants ('blood thinners') such as warfarin (Coumadin), cholestyramine (Questran), colestipol (Colestid), diazepam (Valium), diazoxide (Proglycem), medications that contain estrogen such as hormone replacement therapy (ERT or HRT), and lidocaine (Lidoderm, Xylocaine).

  3. tell your doctor if you have any type of cancer and if you have or have ever had breast lumps or breast cancer; heart failure; kidney disease; or liver disease. If you have ever taken estrogen, tell your doctor if your triglycerides increased during your treatment.

  4. you should not use raloxifene unless you have already undergone menopause and cannot become pregnant. However, tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding.

  5. you should know that raloxifene has not been found to cause spotting or menstrual-like bleeding nor to increase the risk of cancer of the lining of the uterus. Tell your doctor if you develop vaginal bleeding or spotting. Your doctor will need to examine you or order tests to find the cause of the bleeding.

  6. you should know that although raloxifene decreases the chance that you will develop invasive breast cancer, there is still a risk that you will develop this condition. You will still need regularly scheduled breast exams and mammograms before you start taking raloxifene and during your treatment with raloxifene. Call your doctor if you notice tenderness, enlargement, lumps, or any other changes in your breasts.

  7. if you are taking raloxifene to treat osteoporosis, talk to your doctor about other things you can do to prevent osteoporosis from developing or worsening. Your doctor will probably tell you to avoid smoking and drinking large amounts of alcohol and to follow a regular program of weight-bearing exercise.

Certificate of Analysis


ITEMSSPECIFICATIONRESULT
AppearanceWhite &off-white powderConforms
GradeAnti Estrogen SteroidsConforms
SolubilitySoluble in 10% sodium hydroxide solution. Slightly Soluble in methanol. Insoluble in waterConforms
IdentificationsInfrared AbsorptionConforms
Loss on drying≤0.5%0.4%
Residue on ignition≤0.1%0.06%
Heavy metals≤10ppmConforms
Raloxifene Impurity1≤0.20 %0.10%
Any unspecified individual impurity 2≤0.10%Max. 0.08%
Total impurities≤0.50%0.40%
Raloxifene≥98.0%99.0%

Article illustration

Company Profile Introduction

You may like

Recommended supplier

Product name Price   Suppliers Update time
$30.00/1kg
Anhui Ruihan Technology Co., Ltd
2023-09-06
$1.00/1g
Hebei Endun Biological Technology Co. LTD
2023-03-16
$1330.00/1kg
VIP3Y
Wuhan Senwayer Century Chemical Co.,Ltd
2022-10-13
$9.90/10g/Bag
Shanghai Biolang Biotechnology Co., Ltd.
2022-01-07
$15.00/1KG
Zhuozhou Wenxi import and Export Co., Ltd
2021-07-11
$1.10/1g
VIP4Y
Dideu Industries Group Limited
2021-06-30
$10.00/1g
VIP4Y
Wuhan Nutra Biotechnology Co.,Ltd
2021-05-27
$3.00/3ASSAYS
VIP7Y
Career Henan Chemical Co
2019-07-09
$15.00/1KG
Zhuozhou Wenxi import and Export Co., Ltd
2021-07-09
$15.00/1KG
Zhuozhou Wenxi import and Export Co., Ltd
2021-06-26
INQUIRY
田遠洋
15372914669
kt15372914669@163.com